DIVI S LABORATORIES LTD vs RPG LIFE SCIENCES LTD

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and RPG LIFE SCIENCES LTD (RPGLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, RPG LIFE SCIENCES LTD leads DIVISLAB vs RPGLIFE on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
25.81
10.72
P/B ratio
7.26
0.44%
Dividend yield
0.90%
₹96.73
EPS
₹110.79

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
19.03%
22.00%
Return on capital
33.00%
33.00%
EBITDA margin
25.00%
24.32%
Net margin
28.02%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
11.31%
12.10%
Profit CAGR (3Y)
19.20%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹4,724 Cr
₹10,560 Cr
Revenue
₹653 Cr
₹2,568 Cr
Net profit
₹183 Cr
0.00
Debt / equity
0.03
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
RPG LIFE SCIENCES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 28.8%"]
  • ["Stock is trading at 7.81 times its book value", "Debtor days have increased from 46.5 to 60.2 days.", "Working capital days have increased from 44.6 days to 63.7 days"]
DIVI S LABORATORIES LTD full analysis RPG LIFE SCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.